跳至主要内容
临床试验/EUCTR2007-007882-19-IT
EUCTR2007-007882-19-IT进行中(未招募)不适用

A pilot, randomized trial to evaluate the lipid profile after antiretroviral regimens including nevirapine or atazanavir boosted with ritonavir in HIV-positive patients naive for antiretrovirals - STAR2

AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA0 个研究点开始时间: 2007年12月21日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -HIV infected subjects aged 18 years or older
  • -creatinine Clearance>80 ml/min
  • -art- naive
  • -platelet count >50000/mmc
  • -total neutrophils >750 cell/mmc
  • -hemoglobin >10g/dlupper normal value
  • -bilirubin total < 1.5 mg/d
  • -Signed and dated written informed consente
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -women with CD4 >250 cell/mmc
  • -menCD4 >400 cell/mm
  • - pregnant womaen or women who are breastfeeding
  • -alcohol or drag abuse or any condition which might compromise the aderence of the patients to the treatment
  • -Proteinuria >300 mg/24 ore
  • -liver cirrhosis
  • -prior treatment with citotoxics chemiotherapeutic agents and any agents which can induce kidney damage

研究者

发起方
AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA

相似试验